From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Notable Biodefense Contracts: DARPA Award to UMBC

by Global Biodefense Staff
April 26, 2013

The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:

The University of Maryland-Baltimore County (UMBC), Baltimore, Md., is being awarded a $7,899,583 cost-reimbursement contract by the Defense Advanced Research Projects Agency (DARPA) for research and development in support of the Biologically-Derived Medicines on Demand (Bio-MOD) program to provide battlefield medical supply for front line military medics that is responsive to emergency settings and emergent in-theater needs.

The contract includes one, 24-month option which, if exercised, would bring the potential value of this contract to $15,598,291.  Work will be performed in Baltimore, Md., and work is expected to be completed April 24, 2015.  If options are exercised, work will continue through April 2017.

Fiscal 2013 Research, Development, Test and Evaluation funds will be obligated at the time of award.  Contract funds will not expire at the end of the current fiscal year.  This contract was competitively procured via broad agency announcement (BAA 12-37), and published on the Federal Business Opportunities website, with twelve offers received.  The Space and Naval Warfare Systems Center Pacific, San Diego, Calif., is the contracting activity (N66001-13-C-4023). 

Source: DoD Contracts

From Our Partners
Tags: AwardsDARPA

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC